Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 25Multiple Myeloma 13Prostatic Neoplasms 10Osteoporosis 8Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 5Fractures, Bone 4Neoplasms, Plasma Cell 3Lymphoma 3Bone Diseases, Metabolic 3Bone Diseases 3Spinal Cord Compression 2Pain 2Ovarian Neoplasms 2Osteosarcoma 2Lung Neoplasms 2Kidney Neoplasms 2Hematologic Neoplasms 2Carcinoma, Renal Cell 2Bone Neoplasms 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Pleural Effusion, Malignant 1Paraproteinemias 1Oligodendroglioma 1Neoplastic Processes 1Neoplastic Cells, Circulating 1Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

Zoledronic Acid 2Denosumab 2Radiotherapy 1Radiosurgery 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Spinal Cord Compression × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00330759 2022-11-07

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Amgen

Phase 3 Completed
1,779 enrolled 14 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Spinal Cord Compression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡